FindTrial
Sign In

Monitoring of quality of life and chronic complications in patients following hematopoietic stem cell transportation

Monitoring of quality of life and chronic complications in patients following hematopoietic stem cell transportation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016972
Enrollment
Unknown
Registered
2018-07-05
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematology malignancy

Interventions

Case series:allogeneic hematopoietic stem cell transplantation

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Hematology malignancy receiving allogeneic hematopoietic stem cell transplantation; 2. Survive more than 1 month; 3. Regularly follow up.

Exclusion criteria

Exclusion criteria: 1. Die or relapse within 1 month after transplantation; 2. Do not agree to joint the trial.

Design outcomes

Primary

MeasureTime frame
Quality of life;—

Secondary

MeasureTime frame
Chronic complication;Overall survival;Relapse;Non-relapse mortality;Disease-free survival;—

Countries

China

Contacts

Public ContactXiao-Dong Mo

Peking University People's Hospital

mxd453@163.com+86 13810096698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026